Lucid Diagnostics Inc. share price logo

Lucid Diagnostics Inc. Share Price

NASDAQ: LUCD

Small Cap

$1.20

-0.05

(-4.40%)

as on

Lucid Diagnostics Inc. Stock Performance

as on March 25, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $1.18
    $1.25
    downward going graph

    1.67%

    Downside

    4.17%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.95
    $1.80
    downward going graph

    20.87%

    Downside

    50.00%

    Upside

    downward going graph

Lucid Diagnostics Inc. share price movements today

Previous Close
$1.25
Open
$1.23
Volume
853.9K
Day's Low - High
$1.18 - $1.25
52 Week Low - High
$0.95 - $1.80

Lucid Diagnostics Inc. Historical Returns

1 Month Return
-14.38 %
3 Month Return
+ 12.61 %
1 Year Return
-19.35 %
3 Year Return
-10.71 %
5 Year Return
0 %

Lucid Diagnostics Inc. Stock Fundamentals & Key Indicators

Check Lucid Diagnostics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$163.9M

EPS (TTM)

-0.4333

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.92

Industry PE ratio

-4.738881355932204

PEG Ratio

0

EBITDA

-47.1M

Revenue (TTM)

4.4M

Profit Margin

0.00%

Return On Equity TTM

-331.24%

Lucid Diagnostics Inc. Stock Valuation

Track how Lucid Diagnostics Inc. P/E has moved over time to understand its valuation trends.

Lucid Diagnostics Inc. in the last 5 years

  • Overview

  • Trends

Lowest (-4.47x)

December 31, 2021

Industry (-4.74x)

March 25, 2026

Today (-0.92x)

March 25, 2026

Highest (-0.69x)

June 30, 2024

LowHigh

Today’s Price to Earnings Ratio: -0.92x

Lucid Diagnostics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lucid Diagnostics Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Lucid Diagnostics Inc. image
Lucid Diagnostics Inc.
BUY$163.9MNA-0.920.00%
Boston Scientific Corp. image
Boston Scientific Corp.
BUY$103.1B83.39%35.8114.44%
Stryker Corporation image
Stryker Corporation
BUY$128.5B41.32%40.0112.92%
Medtronic Plc image
Medtronic Plc
BUY$110.6B-25.23%24.0713.00%
Abbott Laboratories image
Abbott Laboratories
BUY$183.3B-11.93%28.3514.72%
See all

Stock Returns calculator for Lucid Diagnostics Inc. Stock including INR - Dollar returns

The Lucid Diagnostics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Lucid Diagnostics Inc. investment value today

Current value as on today

₹86,960

Returns

₹13,040

(-13.04%)

Returns from Lucid Diagnostics Inc. Stock

₹22,581 (-22.58%)

Dollar Returns*

₹9,541 (+9.54%)

Analyst Recommendation on Lucid Diagnostics Inc. Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Lucid Diagnostics Inc.. Average target price of $3.95

Lucid Diagnostics Inc. Share Price Target

Get share price movements and forecasts by analysts on Lucid Diagnostics Inc..

What analysts predicted

69.62%UPSIDE

Target Price

$3.95

Current Price

$1.2

Analyzed by

12 Analysts

Target

$3.95

Lucid Diagnostics Inc. target price $3.95, a slight upside of 69.62% compared to current price of $1.2. According to 12 analysts rating.

Lucid Diagnostics Inc. Stock’s Investor Sentiment and Interest

Search interest for Lucid Diagnostics Inc. Stock has decreased by -55% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-55% versus previous 30 day period

Lucid Diagnostics Inc. Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
0
0
1
1
0
1
1
0
1
1
Gross Profit
-1
0
0
0
0
0
0
0
0
0
Operating Income
-11
-11
-11
-10
-11
-11
-12
-12
-11
-11
EBITDA
-10
-13
-10
-10
-10
-12
-11
-26
-4
-11
Interest Expense
0
0
0
0
0
0
0
0
0
2
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-11
-14
-10
-10
-11
-12
-11
-26
-4
-10
Income Tax Expense
0
-2
-1,960
7,496
-
-12,358
7,496
9,110
3,449
-
Net Income
-11
-14
-10
-10
-11
-12
-11
-26
-4
-10
Net Profit Margin
-7157.86%
-1814.56%
-1041.35%
-1060.14%
-1127.56%
-1055.55%
-964.16%
-3249.76%
-381.69%
-858.55%

Lucid Diagnostics Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
0
0
2
4
Gross Profit
-
-
0
-3
-6
-3
Operating Income
-4
-8
-27
-56
-48
-46
EBITDA
-4
-8
-27
-54
-49
-44
Interest Expense
-
-
0
0
0
0
Depreciation
-
-
0
1
2
1
Income Before Tax
-4
-8
-28
-56
-52
-45
Income Tax Expense
-4
-8
0
1
2
7,496
Net Income
-4
-8
-28
-56
-52
-45
Net Profit Margin
0.00%
0.00%
-5615.60%
-14899.47%
-2169.11%
-1047.61%

Lucid Diagnostics Inc. Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-14
-10
-10
-11
-12
-11
-26
-4
-10
Operating Cash Flow
-8
-9
-12
-11
-10
-9
-12
-10
-10
Investing Cash Flow
0
0
0
-
0
0
0
0
0
Financing Cash Flow
0
5
18
11
0
17
15
16
27
Change in Cash
-8
-5
5
0
-10
7
2
5
16

Lucid Diagnostics Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-4
-8
-28
-56
-52
-45
Operating Cash Flow
-2
-5
-17
-29
-32
-44
Investing Cash Flow
0
0
0
-4
0
0
Financing Cash Flow
2
5
72
2
29
48
Change in Cash
0
0
53
-31
-3
3

Global Institutional Holdings in Lucid Diagnostics Inc.

Funds
Holdings
Lido Advisors, LLC
0.29%
Alyeska Investment Group, L.P.
0.72%
Luminus Management, LLC
0.28%
Jane Street Group LLC
0.28%
Morgan Stanley - Brokerage Accounts
0.46%
See all

Insights on Lucid Diagnostics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 828.0K → 1.21M (in $), with an average increase of 16.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Boston Scientific Corp. has given 1.6% return, outperforming this stock by 12.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp. has given 15.1% return, outperforming this stock by 34.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -4.43M → -10.39M (in $), with an average decrease of 134.2% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, LUCD stock has moved down by -6.7%

About Lucid Diagnostics Inc.

Lucid Diagnostics Inc. is a commercial-stage medical diagnostics technology company. The Company is focused on patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux or simply reflux, that leads to esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma (EAC). The Company’s products include EsoGuard and EsoCheck. EsoGuard is a bisulfite-converted next generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells in office procedures. It consists of a vitamin pill-sized rigid plastic capsule tethered to a thin silicone catheter from which a soft silicone balloon with textured ridges emerges to swab surface esophageal cells. It is also developing EsoCure, is an Esophageal Ablation Device, which is a technology that allows a clinician to treat dysplastic BE.
OrganisationLucid Diagnostics Inc.
Headquarters360 Madison Avenue, New York, NY, United States, 10017
IndustryHealthcare
CEODr. Lishan Aklog M.D.
E-voting on sharesClick here to vote

Key Management of Lucid Diagnostics Inc.

Name

Title

Mr. Shaun M. O'Neill M.B.A.

President & COO

Dr. Joseph Willis M.D.

Co-founder & Strategic Advisor

Dr. Brian J. deGuzman M.D.

Chief Technology & Compliance Officer

Dr. Suman M. Verma M.D., Ph.D.

Chief Scientific Officer

Mr. Matthew Riley

Director of Investor Relations

Dr. Lishan Aklog M.D.

Chairman & CEO

Mr. Michael Adam Gordon

General Counsel & Secretary

Dr. Sanford D. Markowitz M.D., Ph.D.

Co-Founder & Strategic Advisor

Dr. Amitabh Chak M.D.

Co-Founder & Strategic Advisor

Helen Moinova Ph.D.

Co-Founder & Strategic Advisor

FAQs

What is Lucid Diagnostics Inc. share price today?

Lucid Diagnostics Inc. share price today is $1.2 as on at the close of the market. Lucid Diagnostics Inc. share today touched a day high of $1.25 and a low of $1.18.

What is the 52 week high and 52 week low for Lucid Diagnostics Inc. share?

Lucid Diagnostics Inc. share touched a 52 week high of $1.8 on and a 52 week low of $0.95 on . Lucid Diagnostics Inc. stock price today i.e. is closed at $1.2,which is 33.33% down from its 52 week high and 26.38% up from its 52 week low.

What is Lucid Diagnostics Inc.'s market capitalisation today?

Lucid Diagnostics Inc. market capitalisation is $0.00T as on .

How to invest in Lucid Diagnostics Inc. Stock (LUCD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Lucid Diagnostics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lucid Diagnostics Inc. Shares that will get you 1.2500 shares as per Lucid Diagnostics Inc. share price of $1.2 per share as on March 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy Lucid Diagnostics Inc. Stock (LUCD) from India?

Indian investors can start investing in Lucid Diagnostics Inc. (LUCD) shares with as little as ₹93.734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.34 in Lucid Diagnostics Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Lucid Diagnostics Inc. share’s latest price of $1.2 as on March 25, 2026 at 1:29 am IST, you will get 8.3333 shares of Lucid Diagnostics Inc.. Learn more about fractional shares .